From: Impact of COVID-19 on urgent gastrointestinal surgery outcomes: increased mortality in 2020
Outcome 90 days after surgery | Univariate (n = 2692) | Multivariate (n = 2692) | ||||||
---|---|---|---|---|---|---|---|---|
Alive | Deceased | OR | CI | P | OR | CI | P | |
Charlson score (n = 2692) | 1[0–4] | 8[6–12] | 1.4 | 1.3–1.4 | < 10–3 | 1.4 | 1.3–1.4 | < 10–3 |
Male gender (n = 1461) | 1381(54.5%) | 80(51.0%) | 0.9 | 0.6–1.2 | 0.390 | 0.7 | 0.5–1.1 | 0.092 |
ICU admission (n = 331) | 240(9.5%) | 91(58.0%) | 13.2 | 9.4–18.6 | < 10–3 | 6.9 | 4.6–10.4 | < 10–3 |
SARS-CoV-2 positive (n = 184) | 74(2.9%) | 10(6.4%) | 2.3 | 1.1–4.3 | 0.019 | 1.2 | 0.5–2.8 | 0.638 |
LOS, days (n = 2692) | 3.76[1.7–8.8] | 11.59[3.5–29.5] | 1.0 | 1.0–1.0 | < 10–3 | 1.0 | 1.0–1.0 | 0.039 |
Year of surgery | ||||||||
2018 (n = 541) | 509(20.1%) | 32(20.4%) | 0.6 | 0.3–0.9 | 0.018 | 0.6 | 0.4–1.2 | 0.134 |
2019 (n = 624) | 598(23.6%) | 26(16.6%) | 0.4 | 0.2–0.6 | < 10–3 | 0.4 | 0.2–0.7 | 0.001 |
2020 (n = 394) | 354(14.0%) | 40(25.5%) | – | – | – | – | ||
2021 (n = 533) | 507(20%) | 26(16.6%) | 0.5 | 0.3–0.8 | 0.002 | 0.4 | 0.2–0.8 | 0.009 |
2022 (n = 600) | 567(22.4%) | 33(21.0%) | 0.5 | 0.3–0.8 | 0.007 | 0.5 | 0.3–1.0 | 0.040 |